おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
Cylene Pharmaceuticals
About
Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $26.30M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Cylene Pharmaceuticals, Inc., a biotech pharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs that target nucleolus and kill cancer cells. It offers nucleolus targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors; and serine/threonine protein kinase inhibitors. The company also provides pre-clinical stage oral drug candidates. Cylene Pharmaceuticals, Inc. was founded in 1997 as Cyternex, Inc. and changed its name to Cylene Pharmaceuticals, Inc. in October 2003. The company is based in San Diego, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 26, 2005 | Series B | $26.30M | 2 |
|
— | Detail |
| Oct 17, 2001 | Series A | $3.50M | 1 |
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
|
|
Yes | Series A |
|
|
— | Series B |
